JPWO2022225035A1 - - Google Patents
Info
- Publication number
- JPWO2022225035A1 JPWO2022225035A1 JP2023515528A JP2023515528A JPWO2022225035A1 JP WO2022225035 A1 JPWO2022225035 A1 JP WO2022225035A1 JP 2023515528 A JP2023515528 A JP 2023515528A JP 2023515528 A JP2023515528 A JP 2023515528A JP WO2022225035 A1 JPWO2022225035 A1 JP WO2022225035A1
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Virology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Epidemiology (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021072888 | 2021-04-22 | ||
| PCT/JP2022/018510 WO2022225035A1 (ja) | 2021-04-22 | 2022-04-22 | Ｂ型肝炎ウイルスに対する抗ウイルス効果を有する胆汁酸誘導体 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPWO2022225035A1 true JPWO2022225035A1 (https=) | 2022-10-27 |
Family
ID=83723044
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023515528A Pending JPWO2022225035A1 (https=) | 2021-04-22 | 2022-04-22 |
Country Status (2)
| Country | Link |
|---|---|
| JP (1) | JPWO2022225035A1 (https=) |
| WO (1) | WO2022225035A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG11202001685TA (en) | 2017-08-28 | 2020-03-30 | Enanta Pharm Inc | Hepatitis b antiviral agents |
| IL283190B2 (en) | 2018-11-21 | 2025-08-01 | Enanta Pharm Inc | Functionalized heterocycles as antiviral agents |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPWO2019139126A1 (ja) * | 2018-01-11 | 2021-04-08 | 国立大学法人 東京大学 | Ｎｔｃｐ阻害剤 |
| US20210346401A1 (en) * | 2018-09-25 | 2021-11-11 | Yichang Humanwell Pharmaceutical Co., Ltd | Regulator of tgr5 signaling as immunomodulatory agent |
| CN114729371B (zh) * | 2019-10-07 | 2024-04-19 | 国立研究开发法人理化学研究所 | 能够抑制乙型肝炎病毒(hbv)对人肝细胞的感染的与人ntcp结合的抗体 |
-
2022
- 2022-04-22 JP JP2023515528A patent/JPWO2022225035A1/ja active Pending
- 2022-04-22 WO PCT/JP2022/018510 patent/WO2022225035A1/ja not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2022225035A1 (ja) | 2022-10-27 |
Similar Documents
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20250217 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20260414 |